Latest by Martha Kempner
The vaccine for human papillomavirus got a bad rap when it debuted. And yet time has shown it's very effective in reducing cancers linked to HPV.
This population is under-represented in HIV data, and few prevention or treatment interventions exist to support them. A new meta-analysis hopes to paint a picture of what's needed.
An in-depth update on what we know about HCV risk, symptoms, screening, outcomes, and treatment (including financial barriers).
A new study adds to mounting evidence that all people should be screened and offered the vaccine for human papillomavirus.
Advocates say the move is more politics than science.
New Study Finds HPV Infection High -- and Vaccination Rates Low -- in Young Sexual Minority Men and Transgender Women
More awareness of human papillomavirus is needed for gay/bisexual men and transgender women of color -- and their health care providers, research suggests.
More research is needed to understand the connections between HIV, mental health, and the neurocircuitry that controls executive function.
A leading researcher at the Centers for Disease Control and Prevention addressed community concerns that surveillance data will be used to put people in prison under HIV criminalization laws.
The HIV-resistant gene mutation CCR5 delta 32 has an interesting past. Could it also be the future of HIV treatment and prevention?
A new systematic review conducted by researchers at the CDC estimates that 14% of trans women and 3% of trans men are living with HIV. The estimate in trans women is lower than previous calculations, but still shows that trans people are a vulnerable population with a substantial risk of contracting HIV.